FDA rejects Aveo kidney cancer drug, asks for additional trial
(Reuters) - Aveo Oncology said the Food and Drug Administration denied approval for its experimental kidney cancer drug citing incon...
Read More »
(Reuters) - Aveo Oncology said the Food and Drug Administration denied approval for its experimental kidney cancer drug citing incon...
Read More »By Ben Hirschler LONDON (Reuters) - AstraZeneca is to buy U.S. respiratory drug specialist Pearl Therapeutics for up to $1.15 billio...
Read More »By Dorene Internicola NEW YORK (Reuters) - For Brendan Brazier it all started with a smoothie. The former Ironman triathlete and ult...
Read More »ZURICH (Reuters) - Swiss pharmaceuticals company Roche Holding AG said on Monday the European Medicines Agency has approved its rheu...
Read More »By Ransdell Pierson (Reuters) - French drugmaker Sanofi SA said the U.S. Food and Drug Administration had approved its four-strain i...
Read More »By Sophie Sassard LONDON (Reuters) - Ireland's Elan has attracted the interest of a number of mid-sized drug companies and a cash of...
Read More »(Reuters) - Biotechnology company Gilead Sciences Inc said the U.S. Food and Drug Administration (FDA) granted priority review to it...
Read More »By Kerry Grens NEW YORK (Reuters Health) - People who go on an extremely low calorie diet are more likely to develop gallstones than...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Drugs that are often used in emergencies and typically kept in ambulances may deteri...
Read More »By Kathryn Doyle NEW YORK (Reuters Health) - Rape victims treated with psychotherapy are still more than twice as likely to have sex...
Read More »